TY - JOUR ID - TI - Peritonsillar Infiltration with Tramadol or Bupivacaine to Relief Post-Tonsillectomy Pain in Children AU - Ali A.K. Abutiheen AU - Ammar Gany Yassin AU - Hadeer Jabbar Dakhal AU - Esam Shyaa khudhair PY - 2020 VL - 13 IS - 2 SP - 2377 EP - 2383 JO - Karbala Journal of Medicine مجلة كربلاء الطبية SN - 19905483 29580889 AB - Background: Tonsillectomy is one of the most frequently performed surgical interventions in children. Pain control for pediatric’ patients undergoing tonsillectomy remains problematic.Objectives: To investigate the effects of peritonsillar infiltration of tramadol or bupivacaine in reducing post-tonsillectomy pain in children.Patients and methods: A Quasi-interventional study. One hundred fifty children aged 5–15 years were enrolled, who were scheduled for elective tonsillectomy or adenotonsillectomy at the ENT department. Patients were allocated randomly into three groups with 50 patients in each. Group A received peritonsillar infiltration of tramadol, group B received peritonsillar infiltration of 5ml of 2% Bupivacaine. While equal quantities of isotonic saline were used for infiltration in the control group (C). No significant difference between the groups in relation to age, gender, weight, type of surgery, and duration of the operation. Peritonsillar infiltration was performed after tonsillectomy in all groups, but before tracheal extubation. The visual analog scale (VAS) was used to measure and compare postoperative pain for the three groups.Results: The tramadol group shows a significantly lower pain score in the early postoperative hours compared to the bupivacaine and control groups. Further, the bupivacaine group shows significantly lower pain scores compared to the control group within the first hour postopera-tively. No significant difference was found between the groups in regards nausea and vomit-ing side effects. Conclusions: Peritonsillar tramadol infiltration offers greater control for post-tonsillectomy pain than bupivacaine or placebo in the early postoperative period. With no obvious side ef-fects. Bupivacaine was superior to placebo in reducing early postoperative pain.

ER -